Late potentials assessment - an useful tool for Brugada Syndrome risk stratification
نویسندگان
چکیده
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Brugada syndrome (BrS) is a channelopathy confining an increased risk sudden cardiac death (SCD). Asymptomatic patients (pts) management remains challenging enhancing the necessity for additionally stratification tools. Purpose To evaluate role non-invasive assessment late potentials (LP) based on SA-ECG as tools in BrS cohort. Methods Prospective, observational single-center study pts with following criteria (1) 1 ECG pattern, either spontaneous or drug induced; (2) performed before anti-arrhythmic treatment; (3) minimum follow up duration 12 months. LPs were evaluated by determination total filtered QRS (fQRS); root mean square voltage 40ms terminal portion (RMS40) and low amplitude electric potential component (LAS40) conventional modified right precordial leads. Malignant arrhythmic events (MAEs) defined composite event SCD appropriate ICD shocks. Association relevant factors MAE was conducted Univariate Cox regression analysis, well continuous categorical divided standard cut-offs (fQRS >114ms, RMS40<20µV, LAS40>38ms). A score predicting computed incorporating significant variables. Results 106 fulfilled inclusion (mean age: 48 ± years, 67.9% male), 52 (49.1%) type pattern. The majority asymptomatic at baseline (81.1%) while 13 presented syncope 3 polymorphic VT/cardiac arrest. 10 (7.1%) MAEs documented during 4.7 years - 4 6 Clinical presentation arrest (p <0.001) LP predictors univariate except RMS40 Neither common (male gender, pattern baseline, previous presence pathogenic SCN5A mutation) follow-up– figure 1. Positive cut-offs, all variables leads, significantly associated follow-up – 2. 2 positive represented 4.7-fold (HR 4.693, 95% CI 1.506-14.624, p = 0.008) Conclusion noninvasive SAECG represent useful prognostic tool BrS. identified subset higher who may deserve individualized preventive strategies.
منابع مشابه
Risk Stratification in Brugada Syndrome
Silvia G. Priori, MD, PHD,*†‡ Maurizio Gasparini, MD,§ Carlo Napolitano, MD, PHD,*‡ Paolo Della Bella, MD, Andrea Ghidini Ottonelli, MD,¶ Biagio Sassone, MD,# Umberto Giordano, MD,** Carlo Pappone, MD,†† Giosuè Mascioli, MD,‡‡ Guido Rossetti, MD,§§ Roberto De Nardis MD, Mario Colombo, MS¶¶ Pavia, Rozzano, Milano, Lido di Camaiore, Bentivoglio, Palermo, Ravenna, Bergamo, Cuneo, and Vicenza, Ital...
متن کاملRisk stratification in Brugada syndrome.
Kathryn A Glatter*, Nipavan Chiamvimonvat, Matti Viitasalo, Qing Wang, and Dipika Tuteja Department of Cardiology,University of California, Davis, Sacramento, CA 95817, USA (KAG, NC, DT); Department of Cardiology,Helsinki University Hospital, Helsinki, Finland (MV); and Center for Cardiovascular Genetics and Department of Molecular Cardiology Cardiology, Cleveland Clinic Foundation, Cleveland, ...
متن کاملLate potentials and the Brugada syndrome.
The Brugada syndrome accounts for approximately 20% of cases of sudden cardiac death in patients with structurally normal hearts (1–3). The syndrome is characterized by an ST-segment elevation in right precordial leads (V1 to V3) unrelated to ischemia, electrolyte disturbances or obvious structural heart disease, and is sometimes accompanied by a right bundle branch block (RBBB) morphology of t...
متن کاملBrugada syndrome: Controversies in Risk stratification and Management
In the 18 years since the first description of Brugada Syndrome in a small series of cardiac arrest survivors it has become evident that there is a marked spectrum in phenotype and prognosis. An internal cardiac defibrillator (ICD) is the only established therapy but is associated with significant morbidity. A number of registries have published their data, but risk stratification, particularly...
متن کاملClinical diagnosis and risk stratification in patients with Brugada syndrome.
In patients with Brugada syndrome (BRS), especially those who are asymptomatic, preclinical diagnosis and risk stratification are vital to the prevention of the fatal ventricular arrhythmias. The initial optimism that a diagnosis of BRS could be made simply on the basis of distinct electrocardiographic (ECG) changes (see the following text) has been tempered, both by a high incidence of false-p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Europace
سال: 2023
ISSN: ['1099-5129', '1532-2092']
DOI: https://doi.org/10.1093/europace/euad122.624